Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?

Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy? ChemMedChem. 2016 11 21; 11(22):2468-2473.

View in: PubMed

subject areas

Antineoplastic Agents
Humans
Molecular Structure
Neoplasms
Rad51 Recombinase
Small Molecule Libraries

authors with profiles

Brian Budke
Philip P. Connell